BioPharmaSpec is a UK and US based CRO providing structural and physicochemical protein characterization services.

We help our clients get their biopharmaceutical products into clinical trials more cost effectively and quickly. Our technical expertise includes the structural characterization and physicochemical analysis of recombinant biopharmaceuticals such as biosimilars and biobetters, monoclonal antibodies, Antibody Drug Conjugates (ADCs), blood circulating hormones, gene therapy products and oligonucleotide therapeutics.

Using state-of-the-art Chromatographic and Mass Spectrometric instrumentation and methods, BioPharmaSpec applies expertise built up over 45 years of pioneering research, to assist clients in a number of protein characterization methods including Primary Amino Acid Sequencing, N and C terminal sequencing, Amino Acid Analysis, Peptide Mapping, Disulfide Bridge analysis, Glycan analysis and Higher Order Structure of proteins. 

Our analytical data helps you choose the best cell clone, provide batch to batch comparisons or perform biosimilar testing for biosimilarity and comparability studies. With BioPharmaSpec's support, solid development decisions can be made based on quality analytical data and experience.

Clinical Trials

Pharmaceutical

Biotechnology

BioPharmaSpec

Andrew Reason

Diane Michalski

Astyn Langlois

Lindsay McGowan

The Research and Development team at BioPharmaSpec is dedicated to advancing the characterization of biopharmaceutical products through innovative analytical techniques. Comprising experienced scientists at various levels, the team conducts detailed studies on protein structures and properties, utilizing state-of-the-art chromatographic and mass spectrometric methods. Their efforts play a crucial role in ensuring the quality and efficacy of recombinant biopharmaceuticals, facilitating timely and cost-effective progression into clinical trials for their clients.

Research and Development

About

Team members